WallStreetZenWallStreetZen

NASDAQ: ATRC
Atricure Inc Stock Ownership - Who owns Atricure?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atricure Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Karl S. DahlquistChief Legal Officer2025-06-30822$25.84
$21.24kBuy
Michael H. CarrelPresident CEO Director2025-06-30822$25.84
$21.24kBuy
Salvatore PriviteraChief Technical Officer2025-06-30822$25.84
$21.24kBuy
Douglas J. SeithChief Operating Officer2025-06-30550$25.84
$14.21kBuy
Vinayak DoraiswamyChief Scientific Officer2025-06-30822$25.84
$21.24kBuy
Vinayak DoraiswamyChief Scientific Officer2025-05-282,500$33.44
$83.60kSell
Robert S. WhiteDirector2025-05-0510,000$22.62
$226.20kBuy
Karen PrangeDirector2025-03-056,100$38.12
$232.53kSell
Michael H. CarrelPresident CEO Director2025-03-0143,926$38.74
$1.70MSell
Karl S. DahlquistChief Legal Officer2025-03-019,870$38.74
$382.36kSell

1 of 2

ATRC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATRC insiders and whales buy or sell their stock.

ATRC Shareholders

What type of owners hold Atricure Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Discovery Group I LLC9.80%4,853,117$149.09MInsider
Vanguard Group Inc9.52%4,714,371$144.83MInstitution
Blackrock Inc8.53%4,224,286$129.77MInstitution
Alliancebernstein LP7.43%3,676,849$112.95MInstitution
Hood River Capital Management LLC6.06%2,999,207$92.14MInstitution
Macquarie Group Ltd4.92%2,436,837$74.86MInstitution
Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC4.44%2,196,914$67.49MInstitution
Champlain Investment Partners LLC4.32%2,137,963$65.68MInstitution
Richard M. Johnston3.82%1,892,454$58.14MInsider
Michael D. Hooven3.75%1,855,477$57.00MInsider

1 of 3

ATRC vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATRC76.06%23.94%Net SellingNet Buying
AZTA70.75%29.25%Net BuyingNet Buying
LMAT75.93%24.07%Net SellingNet Selling
PLSE8.44%81.93%Net BuyingNet Selling
BLFS54.91%45.09%Net SellingNet Selling
View Top Medical Stocks

Atricure Stock Ownership FAQ

Who owns Atricure?

Atricure (NASDAQ: ATRC) is owned by 101.42% institutional shareholders, 31.93% Atricure insiders, and 0.00% retail investors. Discovery Group I LLC is the largest individual Atricure shareholder, owning 4.85M shares representing 9.80% of the company. Discovery Group I LLC's Atricure shares are currently valued at $149.09M.

If you're new to stock investing, here's how to buy Atricure stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.